Lv2
144 积分 2023-10-01 加入
Recombinant human thrombopoietin (rh-TPO) for the prevention of severe thrombocytopenia induced by high-dose cytarabine: a prospective, randomized, self-controlled study
13天前
已完结
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis
13天前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
3个月前
已完结
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
3个月前
已完结
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
3个月前
已完结
Stress and cancer: mechanisms, significance and future directions
4个月前
已完结
Clinical and translational attributes of immune-related adverse events
4个月前
已完结
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
4个月前
已完结
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features
4个月前
已完结
皖公网安备34019202002308
